0001209191-19-007776.txt : 20190206
0001209191-19-007776.hdr.sgml : 20190206
20190206165135
ACCESSION NUMBER: 0001209191-19-007776
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190204
FILED AS OF DATE: 20190206
DATE AS OF CHANGE: 20190206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sachdev Amit
CENTRAL INDEX KEY: 0001406338
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 19572090
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-04
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001406338
Sachdev Amit
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, CRO
Common Stock
2019-02-04
4
M
0
1942
86.52
A
48604
D
Common Stock
2019-02-04
4
S
0
1200
186.57
D
47404
D
Common Stock
2019-02-04
4
S
0
742
187.35
D
46662
D
Common Stock
2019-02-04
4
M
0
2155
91.05
A
48817
D
Common Stock
2019-02-04
4
S
0
1120
186.52
D
47697
D
Common Stock
2019-02-04
4
S
0
1035
187.23
D
46662
D
Common Stock
2019-02-04
4
S
0
5000
186.55
D
41662
D
Common Stock
2019-02-04
4
S
0
3625
187.30
D
38037
D
Common Stock
12215
I
Held in Trust
Common Stock
882
I
401(k)
Stock Option (Right to Buy)
86.52
2019-02-04
4
M
0
1942
86.52
D
2027-02-02
Common Stock
1942
15533
D
Stock Option (Right to Buy)
91.05
2019-02-04
4
M
0
2155
91.05
D
2026-02-01
Common Stock
2155
8622
D
Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $186.57 (range $185.99 to $186.90).
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $187.35 (range $187.03 to $187.59).
Open market sales reported on this line occurred at a weighted average price of $186.52 (range $185.90 to $186.89).
Open market sales reported on this line occurred at a weighted average price of $187.23 (range $186.94 to $187.60).
Open market sales reported on this line occurred at a weighted average price of $186.55 (range $185.90 to $186.90).
Open market sales reported on this line occurred at a weighted average price of $187.30 (range $186.92 to $187.63).
The option vests in 16 quarterly installments from 2/3/2017.
The option vests in 16 quarterly installments from 2/2/2016.
/s/ Omar White, Attorney-in-Fact
2019-02-06